New York, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Bronchiectasis Drugs in Development by Stages, Target, MoA, RoA ...
Researchers in Italy describe their findings indicating the combination of type 2-high severe asthma and bronchiectasis should be considered an emerging phenotype. Recent advances have led to ...
Bronchiectasis is a heterogeneous condition and may be encountered as a stand-alone pulmonary disease by primary care clinicians and specialists in pulmonary medicine. Bronchiectasis sometimes ...
LAS VEGAS, Feb. 22, 2022 /PRNewswire/ -- The Bronchiectasis drugs market has been growing at a rapid pace over the years because of factors such as the high presence of Bronchiectasis among the public ...
BRONCHIECTASIS is protean in its expressions as it is sometimes obscure in its origin. The clinical picture varies in individual patients, but common to the severer cases is a history of harassing, ...
An international research team has found that patients with the lung disease bronchiectasis also often display sensitivity to airborne allergens, and has highlighted the particular role that fungi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback